George Scangos' Bold Vision Post author:Sam Post published:October 24, 2017 Post category:BioPharma The former Biogen CEO is making waves at his new venture, Vir Biotechnology. Source: BioSpace You Might Also Like VEXIM Acquired by Stryker in EUR 183M Deal October 24, 2017 Volpara To Showcase Volpara Enterprise DDP Software At July 11, 2017 Novelion to Cut an Unknown Number of Jobs in Restructuring January 25, 2018
